Adaptation in bacterial chemotaxis involves reversible methylation of specific glutamate residues within the cytoplasmic domains of methyl-accepting chemotaxis proteins. The specific sites of methylation in Salmonella enterica and Escherichia coli chemoreceptors, identified 2 decades ago, established a consensus sequence for methylation by methyltransferase CheR. Here we report the in vitro methylation of chemoreceptors from Thermotoga maritima, a hyperthermophile that has served as a useful source of chemotaxis proteins for structural analysis. Sites of methylation have been identified by liquid chromatography-mass spectrometry/ mass spectrometry. Fifteen sites of methylation were identified within the cytoplasmic domains of four different T. maritima chemoreceptors. The results establish a consensus sequence for chemoreceptor methylation sites in T. maritima that is distinct from the previously identified consensus sequence for E. coli and S. enterica. These findings suggest that consensus sequences for posttranslational modifications in one organism may not be directly extrapolated to analogous modifications in other bacteria.
Sensory adaptation to persisting stimulation permits cells to respond with greater sensitivity to temporal changes in stimuli. In Escherichia coli and Salmonella enterica serovar Typhimurium, adaptation during bacterial chemotaxis is in part mediated by reversible covalent modifications of transmembrane chemoreceptors, also referred to as methyl-accepting chemotaxis proteins, in which specific glutamate residues within the cytoplasmic domains are methylated by methyltransferase CheR and demethylated by methylesterase/deamidase CheB (12, 27) . While molecular mechanisms of chemotaxis signal transduction and adaptation have been most extensively studied in E. coli and S. enterica (3, 30) , Thermotoga maritima has been a useful source of chemotaxis proteins for structural characterization in cases where crystallization of mesophilic orthologs has failed (2, 9, 22) .
T. maritima is a thermophilic bacterium that thrives at high temperatures, with an optimal growth temperature of 80°C (25) . This temperature optimum poses difficulties for laboratory studies of bacterial physiology and/or behavior. However, since proteins from this organism continue to be useful for structural characterization, it is advantageous to characterize the in vitro methylation of the T. maritima chemoreceptors as a basis for the generation, manipulation, and interpretation of receptor signaling complexes. The T. maritima genome encodes six different transmembrane chemoreceptors with diverse periplasmic domains and conserved cytoplasmic domains. The C-terminal signaling domains have from 34% to 100% sequence identity in pairwise alignments with each other and between 23% and 29% identity in alignments with the E. coli aspartate chemoreceptor Tar. No ligands for the T. maritima receptors have yet been identified. The T. maritima genome also contains genes encoding the methylating and demethylating enzymes CheR and CheB, as well as receptor deamidase CheD and associated proteins CheC and CheX. The enzyme activities for T. maritima methylesterase CheB with methylated S. enterica Tar as the substrate (1) and deamidase CheD with T. maritima chemoreceptors as the substrate (6) have previously been reported.
The cytoplasmic signaling domains of chemoreceptors have an extended coiled-coil three-dimensional structure (13) and a conserved primary structure (16, 32) . The greatest sequence conservation occurs within a region designated the highly conserved domain (HCD) at the distal tip of the coiled-coil domain, the locus of protein-protein interactions between receptors and the signaling proteins CheA and CheW. The next most highly conserved segments correspond to two regions encompassing the methylation sites. A methylation consensus sequence, Glx-Glx-X-X-Ala-Ser/Thr (modified residue is in bold), was originally proposed (27) based on direct identification of methylation sites in S. enterica Tar (27) and the E. coli serine chemoreceptor Tsr (11) . At some sites, the methylated residue is encoded as Gln and the side chain is deamidated by methylesterase CheB prior to participation in the reversible methylation cycle (11) . Additional methylation sites identified in E. coli Trg, the chemoreceptor that mediates responses to ribose and galactose, conform to this consensus (19) .
It has been widely assumed that the consensus sequence derived from E. coli and S. enterica receptors can be used to identify potential sites of methylation in chemoreceptors of other bacteria. In this study, partially purified T. maritima methyltransferase CheR has been used to methylate the four different T. maritima chemoreceptor cytoplasmic domains representative of all six transmembrane chemoreceptors, and the sites of methylation have been identified by using liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/ MS). Our results establish a distinct consensus methylation sequence for T. maritima chemoreceptors and thus demonstrate that the previously defined consensus methylation se-times. Assays to determine steady-state levels of methylation were performed using a final concentration of 3 M receptor cytoplasmic domains, 0.05 M CheR in 100 mM potassium phosphate, pH 7.0. Samples were preequilibrated for 10 min at 50°C, and methylation was initiated by the addition of [ 3 H]Sadenosylmethionine to a final concentration of 100 M at 162 Ci/mol.
Preparation of samples for mass spectrometry. Methylation of receptors to steady-state levels was performed as described above, except that the reaction volume was increased to 200 l. Reactions were performed in the presence and absence of S-adenosylmethionine without addition of radiolabel, and reactions were carried out for 90 min. Protein samples were denatured and reduced with 7 mM guanidine HCl and 10 mM dithiothreitol at 50°C for 30 min. Reduced cysteine residues were alkylated with 20 mM iodoacetamide at 25°C for 1 h in the dark. Samples were then buffer exchanged into 50 mM NH 4 HCO 3 using a Microcon 10,000 molecular weight cutoff (Millipore). Sequencing-grade trypsin (Promega) was then added to samples at a 1:50 (wt/wt) ratio, and samples were digested overnight at 37°C. In cases where peptides were too large for exact methylation site determination, sequencing-grade Glu-C (Roche) was added to tryptic peptides and incubated overnight at 25°C.
Mass spectrometry. Peptides were injected onto a reverse-phase column (75 m by 15 cm self-packed with Magic C 18 AQ; 3 m; 200 Å; Michrom Bioresources Inc.) using an ultimate nano-liquid chromatography system (Dionex/LC Packings). The column was equilibrated in 0.1% formic acid (solvent A) and eluted with a linear gradient of 2 to 45% solvent B (0.1% formic acid in acetonitrile) at a flow rate of 200 nl/min over 30 min, and peptides were analyzed by electrospray ionization-MS/MS using an LTQ ion trap mass spectrometer (ThermoFinnigan) equipped with a nanospray source (Proxeon Biosystems). Each MS scan was followed by subsequent zoom scans and MS/MS scans of the four most abundant, multiply charged ions, with a dynamic exclusion of 1 min. Data files (.dta) for MS/MS spectra were generated by Bioworks software (ThermoFinnigan) and were searched against a database containing the sequences of T. maritima receptors and methyltransferase CheR, using Sequest (8) and/or the general purpose m. use (GPM) search engine (7) . Search results were further analyzed by manual inspection.
RESULTS
Characterization of in vitro methylation for T. maritima receptors. Receptor cytoplasmic domains have several advantages over full-length transmembrane receptors for biochemical analyses. The cytoplasmic domains do not require solubilization from membranes, and their smaller size simplifies the identification of methylation sites within proteolytic peptides. Furthermore, kinetic analyses of CheR-receptor interactions would be facilitated by a soluble substrate that could be assayed at substantially higher concentrations than those achievable with receptor-enriched membrane fractions. However, previous studies on the methylation of cytoplasmic domains of E. coli and S. enterica receptors showed C-terminal fragments to be poorly methylated compared to full-length receptors (17, 31) . Nonetheless, we examined the methylation rates of both the C-terminal cytoplasmic domains (TM0429c, TM1143c, and TM1428c) and full-length transmembrane receptors (TM0429fl, TM1143fl, and TM1428fl) of T. maritima. Initial rates of methylation were determined with saturating concentrations of receptors using concentrations of T. maritima CheR at which rates were linearly proportional to enzyme concentration ( Table 1 ). The data indicate that T. maritima receptors can be efficiently methylated in vitro at rates comparable to that previously reported for S. enterica receptor methylation at 30°C (1.1 mol CH 3 · mol CheR Ϫ1 · min Ϫ1 [24] ). As expected, for all substrates, the methylation rates for both full-length receptors and cytoplasmic domains increased as the temperature was increased up to 70°C. Interestingly, the methylation rates with the cytoplasmic domains (TM0429c, TM1143c, and TM1428c) were ϳ2-fold higher than the rates with the corresponding full-length receptors (TM0429fl, TM1143fl, and TM1428fl).
We conclude that unlike the cytoplasmic fragments of E. coli and S. enterica receptors, T. maritima receptor cytoplasmic domains are methylated similarly to their full-length counterparts in in vitro methylation reactions.
Methylation of receptor cytoplasmic domains to saturation. The T. maritima genome encodes six different transmembrane chemoreceptors (TM0023, TM0429, TM0918, TM1143, TM1146, and TM1428), with three of these (TM0023, TM0918, and TM0429) possessing identical cytoplasmic domains. Studies were performed using TM0429c, TM1143c, TM1146c, and TM1428c, representative of the entire set of receptors in the T. maritima genome. In order to facilitate the identification of all methylation sites in these receptors, the cytoplasmic domains were methylated to saturation. At the steady-state levels of methylation achieved under the assay conditions, the stoichiometries of methylation were estimated to be 1.7, 2.8, 2.9, and 3.7 mol CH 3 /mol receptor for TM1143c, TM1428c, TM1146c, and TM0429c, respectively (Fig. 1) . The calculated stoichiometries, though subject to significant error due to the estimation of receptor concentration, suggest that TM1143c, TM1146c, TM1428c, and TM0429c contain at least two, three, three, and four methylation sites, respectively, capable of in vitro methylation. It should be noted that the sites methylated in these in vitro assays are likely to represent a subset of the full array of sites that can be methylated in vivo. Additional sites might be exposed by the presence of chemoeffectors or generated by posttranslational deamidation of specific Gln residues. The T. maritima receptors used in these studies were expressed in the absence of CheB and CheD, enzymes that in other bacteria are known to deamidate specific Gln side chains, generating Glu residues which can then be methylated by CheR (6, 11, 15) .
Identification of methylation sites in TM0429c, TM1143c, TM1146c, and TM1428c. For identification of methylation sites, fully methylated and unmethylated cytoplasmic domain samples were prepared by performing in vitro methylation reactions in the presence and absence of S-adenosylmethionine. Parallel reactions with radiolabeled S-adenosylmethionine confirmed that maximum levels of methylation with stoichiometries similar to those in Table 1 had been achieved in the samples prepared for analysis. Initial analysis of the MS/MS data indicated that each receptor contained several methylation sites. Manual interpretation of the MS/MS spectra from trypsin-digested samples prepared in the presence and absence of S-adenosylmethionine was sufficient to identify the exact residue methylated in most cases (Table 2 ). For instance, the peptide LQEISASTEEVTSR from TM1143c had a high Sequest Xcorr score (a measure of the number of peaks of common mass between observed and expected spectra) for methylation taking place at either Glu505 or Glu506 (the bold residues in the peptide). However, manual inspection of the MS/MS spectra revealed the presence of two peaks, m/z 591.43 and m/z 973.5, that can be attributed to methylation occurring at Glu505 and not Glu506 (Fig. 2) . In some cases, however, peptides containing multiple methylation sites were too large for exact site determination. To resolve this matter, additional digestion of TM0429c and TM1428c tryptic peptides was performed with Glu-C, a protease that cleaves specifically at the C termini of unmethylated glutamate residues. The Glu-C digests allowed identification of three additional methylation sites, Glu401 and Glu596 in TM0429c and Glu310 in TM1428c (Table 2) .
In total, 13 methylation sites were identified: 2 sites in TM1143c, 3 sites in TM1428c, and 4 sites in both TM1146c and TM0429c, corresponding well with the stoichiometries estimated from methylation assays, except for TM1146c, which had an additional site identified (Fig. 1) . Integration of peaks of methylated and unmethylated peptides from assays performed in parallel indicated that the identified sites all exhibited significant levels of methylation ranging from ϳ30 to 70% (data not shown). Furthermore, high sequence coverage was obtained from the trypsin and trypsin/Glu-C digests for all receptors (TM0429c, 87%; TM1143c, 88%; TM1146c, 90%; and TM1428c, 85%) (Fig. 3A) . Notably, there was complete coverage of all EE, QE, and EQ pairs, suggesting that all potential methylation sites were observed in the MS/MS analysis. Identification of additional methylation sites in TM1143c and TM1428c. Some methylation sites within E. coli and S. enterica chemoreceptors are encoded as glutamine residues. Deamidation of the side chains by CheB and CheD (6, 11, 15) converts these residues to glutamates, yielding additional sites for methylation. Based on similarities among the initially identified methylation sites in TM0429c, TM1143c, and TM1428c and inspection of the corresponding T. maritima receptor sequences, we predicted Gln274 and Gln498 of TM1143c and Gln499 of TM1428c to be sites of deamidation. Subsequently, we learned that B. R. Crane and colleagues (personal communication) had identified the same two Gln residues in TM1143c as sites of CheD-mediated deamidation. To determine if these confirmed and predicted sites of deamidation could be methylated once deamidated, we constructed deamidated receptors by substituting these glutamine residues with glutamates, yielding TM1143c(Q274EQ498E) and TM1428c(Q499E). These deamidated receptors were then methylated to saturation (data not shown) and analyzed by LC-MS/MS. Methylation was observed at E499 in TM1428c and at E274 but not E498 in TM1143c ( Table 2) . Lack of observed methylation at E498 does not preclude the possibility that this site may be methylated under some conditions in vivo. In total, 15 methylation sites were identified in the four T. maritima chemoreceptors. Additional deamidation sites not examined in this study have recently been reported (6).
DISCUSSION
In bacterial chemotaxis, the signaling effects of ligand binding are counterbalanced by reversible methylation of specific glutamate residues within the cytoplasmic domains of chemoreceptors, resetting the receptor signaling output back to the prestimulus level. While signaling and adaptation have been most extensively characterized in E. coli and S. enterica, T. maritima has emerged as a valuable organism for structural analysis of chemotaxis proteins (2, 4-6, 9, 21, 22, 29). In this study we have taken initial steps towards characterizing in vitro methylation of T. maritima receptors and have identified specific sites within the cytoplasmic domains that can be methylated by methyltransferase CheR in the absence of stimuli.
Including the previously determined deamidation sites (6) and the methylation and deamidation sites identified here, a total of 19 sites have been identified. Interestingly, the identified methylation and deamidation sites clustered to four regions within the receptors and in many cases were found to be arranged in tandem pairs spaced six to seven residues apart. Sequence alignments of the receptor cytoplasmic domains demonstrated that the first tandem pair (methylation region 2) mapped to a similar location for three of the four receptors (Fig. 3) . However, a second tandem pair mapped to two different locations. Sites in TM0429 and TM1428 aligned with one another (methylation region 3), but the sites in TM1143 did not (methylation region 4). Mapping the methylation regions onto the crystal structure of the TM1143 cytoplasmic domain (20) demonstrated that methylation regions 2 and 3 lie spatially near one another, while methylation region 4 of TM1143 is positioned eight helical turns away in the C-terminal direction compared to methylation region 3 (Fig. 3B ).
There were, however, several instances where identified sites were not found in tandem, with the majority of those cases limited to TM1146. In this receptor, all four identified methylation sites (Glu255, Glu284, Glu479, and Glu515) did not have a corresponding site pair. However, for methylation sites 
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a These mutant receptors have undergone site-specific deamidation. b Underlined Glu residues indicate exact sites of methylation, bold residue pairs are methylated sites that could not be resolved in the context of that peptide, and underlined bold residues indicate methylation at Gln-to-Glu substitutions in mutant receptors.
Glu479 and Glu515, this finding was similar to what was observed for methylation site Glu281 in TM1143 and Glu506 in TM1428. In those instances, only after alteration of specific glutamines to glutamates (Q274E in TM1143c and Q499E in TM1428c) were the paired deamidation/methylation sites identified ( Table 2) . Analysis of the TM1146 sequence shows two glutamine residues, Gln472 and Gln508, which align perfectly with previously determined deamidation sites from the other T. maritima receptors (Fig. 3A) , making both Gln472 and Gln508 possible deamidation sites which could potentially form tandem pairs with identified methylation sites Glu479 and Glu515. Chao et al. (6) identified consecutive deamidation sites (Gln282 and Gln283) in TM1428 that mapped upstream of methylation region 2 (Fig. 3) . Similarly, methylation site Glu255 in TM1146 was also found to map to this region (methylation region 1). Despite the presence of glutamate pairs (Glu275, 276 and Glu289, 290 in TM1428 and Glu248, 249 in TM1146) flanking these methylation and deamidation sites, none were identified as methylation sites. It should be noted, however, that similar to methylation regions 2 and 3, mapping methylation regions 1 and 4 onto the TM1143c structure showed methylation region 1 to lie spatially near methylation region 4 on the opposite strand (Fig. 3B) . Clustering of the identified sites located within these four methylation regions to two distinct areas of the receptors likely facilitates the accessibility and efficiency with which the modifying proteins (CheB, CheD, and CheR) alter these sites.
Previous studies directly identifying sites of methylation in E. coli (11, 19) and S. enterica (27) receptors yielded the methylation consensus sequence Glx-Glx-X-X-Ala-Ser/Thr (modified residue is in bold). Since then, this consensus sequence has been used to predict putative methylation sites in chemoreceptors from other organisms (16) and as the basis for identification of methylation sites through indirect methods (10, 23, 33) . The lack of direct chemical analyses has precluded assessment of the universality of this consensus sequence.
In this study, methylation sites in T. maritima receptors were directly identified by utilizing LC-MS/MS. A sequence alignment of the identified methylation and deamidation sites from this study and those recently reported (6) revealed a novel consensus methylation sequence, Ala/Ser-sm-X-Glx-Glu-Xsm-Ala/Ser (modified residues are in bold; sm represents a , that appears as a tandem heptad repeat centered around the Glx-Glu pair and overlaps at the Ala/Ser residue (Fig. 4) . A previous study analyzing receptor cytoplasmic sequences proposed that the original consensus methylation sequence be extended to include residues to the N-terminal side of the Glx-Glx pair (16) , and this extended conservation appears to be a feature of the T. maritima consensus as well. Remarkably, only 2 (E284 and E515 in TM1146) of the 19 methylation and/or deamidation sites that were identified in T. maritima match the E. coli/S. enterica consensus sequence. Moreover, while methylation of E. coli/S. enterica receptors occurs strictly at the second Glx residue within the consensus sequence, methylation of T. maritima receptors occurs primarily at the first Glx within the consensus sequence (Fig. 4) . Methylation of the first Glx residue within the consensus sequence has also been observed in photoreceptor HtrI of Halobacterium salinarum (23) . At some T. maritima methylation and/or deamidation sites, modification occurs at the second Glu residue, and in two cases, both residues of the Glx-Glu pair are modified. No distinguishing features within the local primary sequence of the sites appear to correlate with the choice of the first, second, or both as the site(s) of modification. In the past decade the determination and publication of sequences of entire genomes have increased exponentially. Currently, 339 genomes have been completed, and a staggering 1,502 genome projects are still in progress (http://www .genomesonline.org). As more and more genome sequences become available, comparative genomic analyses will serve as an important tool in identifying consensus sequences and mapping putative sites of posttranslational modification in homologous proteins within and among different organisms. Our results comparing the methylation sites in T. maritima chemoreceptors with previously identified sites in E. coli and S. enterica suggest that direct chemical analysis will be required for conclusive identification of sites of modification. The consensus sequence for methylation sites in T. maritima receptors is distinct from that for E. coli and S. enterica receptors. Even within the T. maritima receptors there are unexpected deviations from the well-conserved T. maritima consensus sequence. For example, methylation site 1 in TM0429 (Fig. 3A and 4) contains a Thr residue in position 1 of the consensus sequence , and TM1428. A multiple sequence alignment was generated with CLUSTAL W (28) using the HCD core (32) (boxed region) to ensure proper alignment. Residues corresponding to methylation regions are bold, identified methylation sites are red (this study), and identified deamidation sites are blue (Gln589 in TM0429, Gln498 in TM1143, and Gln282, 283 in TM1428) (6) . Underlined residues indicate the sequence coverage achieved in MS/MS analysis from trypsin and trypsin/Glu-C digests. (B) Methylation regions mapped onto the structure of the cytoplasmic domains of TM1143 (20) . The domains form a dimeric four-helix bundle, with each monomer folding back on itself at the HCD to generate two antiparallel helices. The TM1143 cytoplasmic domain is a coiled coil and includes residues 225 to 528 for monomers A (blue) and B (gray). The identified methylation regions (red) were mapped onto the corresponding residues of monomer A of the TM1143c dimer to assess the spatial arrangement of the sites. The identified methylation and deamidation sites for each of the receptors are indicated, with residue numbers corresponding to amino acid sequences of full-length receptors.
instead of the Glu/Gln residue that is found in all other methylation sites. Because this site does not match the consensus sequence, its identification as a site of methylation would likely have been missed by methods other than direct chemical analysis of the entire receptor domain. When targeted mutagenesis of predicted sites is used to identify sites of posttranslational modification, sites that deviate significantly from the consensus may be missed. Importantly, the subset of sites identified by this route serves to reinforce the starting sequence and perpetuates a consensus sequence that may not be fully inclusive.
We expected that glutamine residues targeted by deamidation enzymes, once deamidated, would subsequently be methylated. Based on predictions and subsequent confirmation (6) of three sites of deamidation, receptors containing Gln-to-Glu substitutions were constructed and analyzed for methylation. Q499E of TM1428c and Q274E of TM1143c were observed to be methylated, but Q498E of TM1143c was not methylated under in vitro methylation conditions. The lack of methylation at a confirmed deamidation site emphasizes the limitation of using in vitro reactions for identification of modification sites. It is likely that specific in vivo conditions and/or environmental cues may be required for utilization of all modification sites. For example, in Bacillus subtilis, methylation site selection is coordinated by the interaction of CheY with receptors (14, 33) . The absence of CheY as well as the rest of the chemotaxis proteins, full-length receptors, and chemoeffectors in our assays might explain the lack of observed methylation at Q498E. It is important to note that the methylation sites identified by in vitro modification are likely to represent a minimum subset of sites available for methylation in vivo.
In summary, the methylation sites identified within T. maritima receptors have established a consensus sequence that differs from the previously identified consensus sequence for E. coli and S. enterica receptors. Knowledge of the methylation sites in T. maritima receptors provides an important foundation for structural characterization of different receptor signaling states. Additionally, these findings provide cautionary anecdotal evidence that consensus sequences for posttranslational modifications in one bacterium may not necessarily be applicable to analogous modifications in other species.
